TITLE: Poland's Financial Supervision Authority Upholds Financial Penalties Against Hyenergy SA for Market Abuse Violations
BODY:
On February 13, 2026, Poland's Financial Supervision Authority (Komisja Nadzoru Finansowego, KNF) issued a final decision upholding penalties imposed on Hyenergy SA (formerly Inno-Gene SA), a Warsaw-based company, for violations of market abuse regulations.
The KNF's decision, which upheld an earlier determination from January 24, 2025, imposed total financial penalties of 1 million Polish zloty (PLN) across three separate violations of the Market Abuse Regulation (MAR). The violations concerned the company's failure to disclose material non-public information to the public in a timely manner. Specifically, Hyenergy SA was penalised PLN 300,000 for failing to disclose information regarding non-delivery of SARS-CoV-2 RT-LAMP FAST DETECTION KIT products under a contract between DNA Research Centre and LeanTrix, which arose on January 1, 2021. The company was also penalised PLN 500,000 for omitting required information in a current report from November 4, 2020, concerning a distribution agreement with London Europe Group Ltd., and for failing to disclose information about non-delivery under that agreement, which arose by July 1, 2021. Additionally, Hyenergy SA was penalised PLN 200,000 for failing to disclose information regarding a contract concluded on December 30, 2020, between DNA Research Centre and Globalito Ltd., based in London.
All violations constituted breaches of Article 17(1) in conjunction with Article 7 of Regulation (EU) 596/2014 on market abuse. Hyenergy SA may appeal the decision to the Regional Administrative Court in Warsaw.